"Valeo Pharma is about creating partnerships, both with International partners and with members of the Canadian Healthcare Industry, to bring innovative products of the highest quality to the market, quickly and efficiently."
A Canadian company based in Kirkland, Quebec, Valeo Pharma Inc. is a fully integrated, privately held specialty pharmaceutical company founded in 2003. Valeo Pharma is devoted to providing healthcare professionals and patients with the highest quality specialty products and healthcare solutions.
Initially launched as a company specializing in dermatology, over time Valeo Pharma grew into a more diverse company and competed in a variety of specialty markets. Through acquisitions, in-licensing and selective product development, Valeo Pharma brought over 20 products to the market between 2003 and 2013.
In 2014, Valeo Pharma made the strategic decision to exit the dermatology space and concentrate on commercialization of specialized innovative products addressing the needs of patients suffering from complicated or rare diseases.
This strategic shift led to the divestiture of the dermatology portfolio (as well as a few non-dermatology products) to Valeant Canada.
Driven by our experienced management team with in-depth knowledge of the Canadian market conditions and long-standing relationships with key industry leaders and healthcare professionals, our solid business model provides the required resources to successfully introduce specialty products to Canada.
In line with this history and the new company strategy, Valeo Pharma continues to identify and capitalize on opportunities to build the product line, and provide healthcare professionals and patients with therapeutic solutions to meet their needs.